Clinical Trials Directory

Trials / Sponsors / Rain Oncology Inc

Rain Oncology Inc

Industry · 7 registered clinical trials.

StatusTrialPhaseStarted
WithdrawnMilademetan in Combination With Atezolizumab in Patients With Advanced Solid Tumors With CDKN2A Loss
Advanced Solid Tumor, CDKN2A, NSCLC
Phase 1 / Phase 22023-05-19
TerminatedA Study of Milademetan Administration on Cardiac Repolarization in Healthy Subjects
Cardiac Repolarization
Phase 12023-04-17
TerminatedMilademetan in Advanced/Metastatic Solid Tumors
Solid Tumors, Head and Neck Carcinoma, Cholangiocarcinoma
Phase 22021-11-01
TerminatedTreatment of Milademetan Versus Trabectedin in Patient With Dedifferentiated Liposarcoma
Dedifferentiated Liposarcoma
Phase 32021-07-14
TerminatedStudy of Tarloxotinib in Pts With NSCLC (EGFR Exon 20 Insertion, HER2-activating Mutations) & Other Solid Tumo
NSCLC, Stage IV, NSCLC Stage IIIB, NSCLC, Stage IIIC
Phase 22019-03-13
TerminatedStudy for Treatment of Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck or S
Metastatic Head-and-neck Squamous-cell Carcinoma
Phase 22015-08-01
TerminatedStudy for Treatment With TH-4000 (Tarloxotinib) in Epidermal Growth Factor Receptor (EGFR) Mutant, T790M-negat
Non-small Cell Lung Cancer, NSCLC, Non-squamous NSCLC
Phase 22015-06-01